Skip to content

Supplier News

NBTY bolsters senior management team

NBTY bolsters senior management team

NBTY Inc. has appointed four senior executives to its management team, who will be charged with spearheading growth initiatives for the nutritional supplement maker and marketer’s branded businesses. NBTY said Thursday that Andre Branch has joined the company as chief marketing officer.

Takeda U.S.A. names president

Ramona Sequeira has been appointed president of Takeda Pharmaceuticals U.S.A. Inc., a unit of Takeda Pharmaceutical Co. The company said this week that Sequeira will lead all business operations for the United States and report to Christophe Weber, president and chief executive officer of Takeda.

Hi-Tech to acquire Latin America OTC, supplements supplier

Hi-Tech Pharmaceuticals plans to buy Advanced Pharmaceuticals and Nutritionals (APN), a leading supplier of over-the-counter health care products and dietary supplements in the Mexican, Central American, and South American markets. Financial terms of the agreement weren’t disclosed.

Glenmark to ship Lybrel generic

The Food and Drug Administration has granted Glenmark Generics Inc. USA final approval for levonorgestrel/ethinyl estradiol tablets (0.09 mg/0.02 mg), an oral contraceptive. Glenmark said Friday that its levonorgestrel/ethinyl estradiol tablets (0.09 mg/0.

Perrigo set to ship generic version of Exalgo

Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCI extended-release tablets (8 mg, 12 mg and 16 mg), an opioid pain medication. Perrigo said that it expects to begin shipments of the product to pharmacies within the next few weeks.

Glenmark to launch generic of FemHRT

Glenmark Generics Inc. USA, a subsidiary of Glenmark Generics Ltd., has received final approval from the Food and Drug Administration for norethindrone acetate and ethinyl estradiol tablets (0.5 mg/2.5 mcg and 1 mg/5 mcg), a medication for symptoms of menopause.